Alì Taher

23.8k total citations · 7 hit papers
533 papers, 14.6k citations indexed

About

Alì Taher is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Alì Taher has authored 533 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 374 papers in Genetics, 365 papers in Hematology and 61 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Alì Taher's work include Hemoglobinopathies and Related Disorders (353 papers), Iron Metabolism and Disorders (245 papers) and Blood groups and transfusion (96 papers). Alì Taher is often cited by papers focused on Hemoglobinopathies and Related Disorders (353 papers), Iron Metabolism and Disorders (245 papers) and Blood groups and transfusion (96 papers). Alì Taher collaborates with scholars based in Lebanon, United States and Italy. Alì Taher's co-authors include Maria Domenica Cappellini, Khaled M. Musallam, John B. Porter, Vip Viprakasit, D. J. Weatherall, Antoine N. Saliba, Amal El‐Beshlawy, Hussain Isma’eel, Adlette Inati and Antonis Kattamis and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Alì Taher

520 papers receiving 14.2k citations

Hit Papers

Preoperative anaemia and postoperative outcomes in non-ca... 2011 2026 2016 2021 2011 2017 2017 2014 2019 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
    2011 806 citations Khaled M. Musallam, Alì Taher et al. profile →
  2. Thalassaemia
    2017 508 citations Alì Taher, Maria Domenica Cappellini et al. profile →
  3. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management
    2017 321 citations Maria Domenica Cappellini, Alì Taher et al. American Journal of Hematology profile →
  4. Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT)
    2014 303 citations Maria Domenica Cappellini, John B. Porter et al. profile →
  5. Iron deficiency anaemia revisited
    2019 294 citations Maria Domenica Cappellini, Khaled M. Musallam et al. profile →
  6. β-Thalassemias
    2021 234 citations Alì Taher, Khaled M. Musallam et al. profile →
  7. 2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia
    2022 117 citations John B. Porter, Alì Taher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alì Taher Lebanon 58 9.9k 9.7k 1.9k 1.3k 1.1k 533 14.6k
Maria Domenica Cappellini Italy 70 14.0k 1.4× 12.5k 1.3× 4.0k 2.1× 3.0k 2.4× 764 0.7× 565 20.8k
Iain C. Macdougall United Kingdom 49 3.1k 0.3× 6.6k 0.7× 633 0.3× 966 0.8× 931 0.9× 187 12.0k
Khaled M. Musallam Lebanon 42 4.2k 0.4× 4.2k 0.4× 707 0.4× 603 0.5× 714 0.7× 173 6.7k
Nancy F. Olivieri Canada 51 7.3k 0.7× 6.4k 0.7× 2.1k 1.1× 832 0.7× 216 0.2× 169 9.4k
Francesco Locatelli Italy 75 2.9k 0.3× 8.0k 0.8× 1.5k 0.8× 1.2k 1.0× 2.8k 2.6× 539 25.2k
Peter W. Collins United Kingdom 60 2.6k 0.3× 8.0k 0.8× 1.2k 0.6× 543 0.4× 879 0.8× 252 11.9k
Steven Fishbane United States 45 1.9k 0.2× 3.5k 0.4× 486 0.3× 590 0.5× 760 0.7× 179 10.1k
John K. Olynyk Australia 54 3.6k 0.4× 4.5k 0.5× 352 0.2× 537 0.4× 1.3k 1.2× 269 9.9k
Lawrie W. Powell Australia 63 6.3k 0.6× 8.6k 0.9× 463 0.2× 699 0.6× 781 0.7× 295 14.2k
Ingrid Pabinger Austria 73 2.4k 0.2× 10.5k 1.1× 468 0.2× 290 0.2× 2.5k 2.3× 541 20.3k

Countries citing papers authored by Alì Taher

Since Specialization
Citations

This map shows the geographic impact of Alì Taher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alì Taher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alì Taher more than expected).

Fields of papers citing papers by Alì Taher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alì Taher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alì Taher. The network helps show where Alì Taher may publish in the future.

Co-authorship network of co-authors of Alì Taher

This figure shows the co-authorship network connecting the top 25 collaborators of Alì Taher. A scholar is included among the top collaborators of Alì Taher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alì Taher. Alì Taher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taher, Alì, Vip Viprakasit, Antonis Kattamis, et al.. (2025). Efficacy and safety of luspatercept in non–transfusion-dependent β-thalassemia: long-term results from the BEYOND study. Blood Advances. 9(23). 6108–6119.
2.
Bou‐Fakhredin, Rayan, Maria Domenica Cappellini, Alì Taher, & Lucia De Franceschi. (2024). Hypercoagulability in hemoglobinopathies: Decoding the thrombotic threat. American Journal of Hematology. 100(1). 103–115. 4 indexed citations
3.
Sidonio, Robert F., Ana Boban, Adlette Inati, et al.. (2024). von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease. Blood Advances. 8(6). 1405–1414. 10 indexed citations
4.
Saliba, Antoine N., Khaled M. Musallam, & Alì Taher. (2023). How I treat non-transfusion-dependent β-thalassemia. Blood. 142(11). 949–960. 14 indexed citations
5.
Musallam, Khaled M., Alì Taher, Antonis Kattamis, et al.. (2023). Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy. Drug Design Development and Therapy. Volume 17. 1583–1591. 5 indexed citations
6.
Fadhil, Ibtihal, Ali Al‐Zahrani, Zahi Abdul Sater, et al.. (2023). Cancer research in vulnerable populations: A call for collaboration and sustainability from MENATC countries.. Journal of Clinical Oncology. 41(16_suppl). e13649–e13649. 1 indexed citations
7.
Bou‐Fakhredin, Rayan, et al.. (2023). Unmet needs in β-thalassemia and the evolving treatment landscape. Transfusion Clinique et Biologique. 31(1). 48–55. 3 indexed citations
8.
Bou‐Fakhredin, Rayan, Lucia De Franceschi, Irene Motta, et al.. (2022). Redox Balance in β-Thalassemia and Sickle Cell Disease: A Love and Hate Relationship. Antioxidants. 11(5). 967–967. 11 indexed citations
9.
Bou‐Fakhredin, Rayan, Lucia De Franceschi, Irene Motta, Maria Domenica Cappellini, & Alì Taher. (2022). Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective. Pharmaceuticals. 15(6). 753–753. 27 indexed citations
10.
11.
Cappellini, Maria Domenica, John B. Porter, Khaled M. Musallam, et al.. (2015). Development of a new disease severity scoring system for patients with non-transfusion-dependent thalassemia. European Journal of Internal Medicine. 28. 91–96. 10 indexed citations
12.
Fucharoen, Suthat, Adlette Inati, Swee Lay Thein, et al.. (2013). A randomized phase I/II trial of HQK ‐1001, an oral fetal globin gene inducer, in β‐thalassaemia intermedia and H b E /β‐thalassaemia. British Journal of Haematology. 161(4). 587–593. 26 indexed citations
13.
14.
Mahfouz, Rami, et al.. (2011). JAK2 V617F Gene Mutation in the Laboratory Work-Up of Myeloproliferative Disorders: Experience of a Major Referral Center in Lebanon. Genetic Testing and Molecular Biomarkers. 15(4). 263–265. 20 indexed citations
15.
16.
Succar, Julien, Khaled M. Musallam, & Alì Taher. (2011). THALASSEMIA AND VENOUS THROMBOEMBOLISM. SHILAP Revista de lepidopterología. 3(1). e2011025–e2011025. 35 indexed citations
17.
Pennell, Dudley J., John B. Porter, Maria Domenica Cappellini, et al.. (2010). CONTINUED IMPROVEMENT IN CARDIAC T2*WITH DEFERASIROX TREATMENT OVER 2 YEARS: RESULTS FROM THE EXTENSION OF EPIC CARDIAC SUBSTUDY IN BETA-THALASSAEMIA PATIENTS WITH MYOCARDIAL SIDEROSIS. UCL Discovery (University College London). 2 indexed citations
18.
Sabbagh, Audrey, Ziyad Mahfoud, Alì Taher, et al.. (2008). High Prevalence of MTHFR Gene A1298C Polymorphism in Lebanon. Genetic Testing. 12(1). 75–80. 35 indexed citations
19.
Kanaan, Ziad, Rami Mahfouz, Alì Taher, & Raja Sawaya. (2008). Bilateral Transverse Sinus Thrombosis Secondary to a Homozygous C677T MTHFR Gene Mutation. Genetic Testing. 12(3). 363–365. 5 indexed citations
20.
Uthman, Imad, Ismaïl Khalil, Raja Sawaya, & Alì Taher. (2004). Lupus anticoagulant, Factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis. Clinical Rheumatology. 23(4). 362–363. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Domenica Cappellini Breakdown of academic impact, for papers by Iain C. Macdougall Breakdown of academic impact, for papers by Khaled M. Musallam Breakdown of academic impact, for papers by Nancy F. Olivieri Breakdown of academic impact, for papers by Francesco Locatelli Breakdown of academic impact, for papers by Peter W. Collins Breakdown of academic impact, for papers by Steven Fishbane Breakdown of academic impact, for papers by John K. Olynyk Breakdown of academic impact, for papers by Lawrie W. Powell Breakdown of academic impact, for papers by Ingrid Pabinger
Rankless by CCL
2026